Protease Inhibitor Cocktail for bacterial cell extracts (100 X in DMSO) Reference: K1024-1 Inhibit proteolytic degradation during bacterium lysis and protein extraction
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Reference: R1011-5 EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Protease Inhibitor Cocktail for bacterial cell extracts (100 X in DMSO) Reference: K1024-20 Inhibit proteolytic degradation during bacterium lysis and protein extraction
Firefly Luciferase mRNA (ARCA, 5-moUTP) Reference: R1012-.1 Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Protease Inhibitor Cocktail for bacterial cell extracts (100 X in DMSO) Reference: K1024-50 Inhibit proteolytic degradation during bacterium lysis and protein extraction
Firefly Luciferase mRNA (ARCA, 5-moUTP) Reference: R1012-1 Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Protease Inhibitor Cocktail for bacterial cell extracts (100 X in DMSO) Reference: K1024-100 Inhibit proteolytic degradation during bacterium lysis and protein extraction
Firefly Luciferase mRNA (ARCA, 5-moUTP) Reference: R1012-5 Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.